The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. - Wikidata - awgldk - TriplyDB

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

http://www.wikidata.org/entity/Q37415455

about

Single-Domain Antibodies As Therapeutics against Human Viral Diseases.Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice.

P2860

Q47554821-C1BED3F4-9C11-435F-BBA5-0811FC001AF1 Q47555792-0F5D0E42-3E4E-4F94-8275-9D74E4F8E4A3 Q52692811-AE179B0E-7DEF-43B4-8CBF-98EBF80F1619

P2860

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

http://www.wikidata.org/entity/Q37415455

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@en

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@nl

type

label

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@en

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@nl

prefLabel

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@en

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1.

@nl

P1433

Q37415455-49892DF8-DA88-4130-9D3A-6C4FFCF0575E

P1476

Q37415455-5C70E893-D15D-4B3C-A178-AEEC6DFEC24B

P2093

Q37415455-604775C6-9BDA-41D2-8ABE-3EFD7A4AABB9

Q37415455-66ABE700-0268-4313-83F3-59A6FC890C5F

Q37415455-71EA91D6-B8AE-4F7E-B179-FB132A03E17C

Q37415455-C02142F8-F252-4A62-8A19-67F6D1DF07A8

Q37415455-D6E6878B-8EC3-4101-A855-2C5E408B9529

P2860

Q37415455-02C8C3FE-BCA2-44F2-993D-75A51A2B6666

Q37415455-03D1D2E0-92DB-4CA7-B7C5-73375BA36DF4

Q37415455-1AC8249D-C0E3-4073-BAFC-7ED8FBEFC3F6

Q37415455-26276E5A-FCB8-42CD-A54F-F4C50D4B764D

Q37415455-265998FF-FA86-4B9A-A011-0ED145A85917

Q37415455-26FE245E-C958-4746-9A99-13FB678803BE

Q37415455-28B09D47-A785-460C-B2ED-012101C361DF

Q37415455-28C4AA1D-7225-4007-84FE-2BCE57335C4E

Q37415455-2B3F1EBE-3792-4F43-8185-1FB2FC330AAD

Q37415455-2C1458D8-61A0-4F1F-AEA7-4DEE07F77304

P304

Q37415455-962925AB-7869-4681-B594-370D8A5607DA

P31

Q37415455-E8D5E15F-4BF8-4944-80F1-EFC9900D2A8A

P356

Q37415455-2C7E83E2-524E-4B3B-AE34-C358744E5CB7

P407

Q37415455-F0B3BA4D-AB34-40B1-85CB-4E545172864A

P433

Q37415455-7B02B4F6-FEFB-4904-BD50-1C20E78277E8

P478

Q37415455-CB391A8F-439F-4443-B10C-768E18AD8EF0

P50

Q37415455-38571C8D-C210-44F8-9D57-43163BFADF0C

Q37415455-7F48C08A-F2C3-4582-BBEA-940C00DE8DD8

Q37415455-85331762-1D8D-4E4D-A937-7336173143DD

Q37415455-91083041-1CF4-4038-8E63-D4A66B09C6F6

Q37415455-C437A363-38AB-4360-B54F-EBA077685AEE

P577

Q37415455-7952592F-D1BE-43AD-A648-CF3450724F58

P698

Q37415455-1EFDF0F4-75E3-41CF-A25C-08C5608B6942

P932

Q37415455-9D8B7EFB-BE22-4D78-891F-FDD80C2E1A00

P356

P1433

Journal of Virology

P1476

The Glycosylphosphatidylinosit ...... Immunodeficiency Virus Type 1

@en

P2093

Chaobaihui Ye

http://www.w3.org/2001/XMLSchema#string

Julie Matz

http://www.w3.org/2001/XMLSchema#string

Lucie Bracq

http://www.w3.org/2001/XMLSchema#string

Paul Zhou

http://www.w3.org/2001/XMLSchema#string

Weiming Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research

Virus entry, assembly, budding, and membrane rafts

Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

P304

10642-10659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01559-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Jason T. Kimata

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27654286

http://www.w3.org/2001/XMLSchema#string

P932

5110191

http://www.w3.org/2001/XMLSchema#string